SMTL ID : 8k5r.1

CDK9/cyclin T1 in complex with KB-0742

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.75 Å

Oligo State

hetero-1-1-mer

Ligands

1 x VQE: (1S,3S)-N3-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine(Non-covalent)

VQE.1: 12 residues within 4Å: Chain A: I.25, A.46, F.103, D.104, F.105, C.106, E.107, H.108, D.109, A.153, L.156, D.167 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.46, A:F.103, A:F.105, A:L.156, A:L.156 Hydrogen bonds: A:C.106, A:C.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Freeman, D.B. et al., Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. J.Med.Chem. (2023)

Release Date

2023-12-06

Peptides

Cyclin-dependent kinase 9: A
Cyclin-T1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 9

Cyclin-T1